Loading...
XSHE
002286
Market cap496mUSD
Dec 05, Last price  
9.22CNY
1D
3.48%
1Q
-14.15%
Jan 2017
-45.09%
IPO
3.48%
Name

Baolingbao Biology Co Ltd

Chart & Performance

D1W1MN
XSHE:002286 chart
P/E
31.57
P/S
1.46
EPS
0.29
Div Yield, %
0.87%
Shrs. gr., 5y
0.03%
Rev. gr., 5y
5.88%
Revenues
2.40b
-4.84%
257,342,744414,325,569536,554,950525,399,637720,615,475950,773,441978,027,983900,769,114910,710,3221,196,281,6961,377,424,2591,592,996,1891,730,012,4581,805,170,0752,054,578,2682,764,976,9722,712,745,3172,523,914,0072,401,754,836
Net income
111m
+105.97%
20,007,53033,296,28744,777,23439,273,83642,804,52555,721,63567,325,73841,931,12823,922,42640,945,99349,342,74349,621,88742,952,99535,233,72249,861,881201,579,400133,168,83953,969,019111,159,811
CFO
249m
-11.89%
19,121,86178,975,088110,771,42644,510,31027,448,383171,698,98394,152,65285,597,750101,769,16977,485,824108,983,6130133,050,032153,953,675398,458,455206,267,70230,821,782282,283,397248,722,360
Dividend
Mar 08, 20240.08 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Baolingbao Biology Co.,Ltd. manufactures corn-based health and food ingredients in China and internationally. The company offers isomalto-oligosaccharide, galacto-oligosaccharides, fructose-oligosaccharides, and erythritol products; high fructose corn syrups, crystalline fructose products, sugar alcohols, and resistant dextrin-soluble corn fiber and polydextrose products; starch sugars, such as trehalose, maltodextrin, and glucose syrup products; terminal products; and corn steep liquors, corn husk sprayed products, and corn gluten meal products. Its products are used in various food items, such as beverages, dairy, bakery, candy, meat, honey, seafood, canned food, condiment, health food, infant nutrition, fermentation, and animal nutrition, as well as in various fields, including daily chemicals, pharmaceuticals, cosmetics, etc. The company was founded in 1997 and is based in Yucheng, China.
IPO date
Aug 11, 2009
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT